We must improve conditions and options for Australian ECRs

Nat Hum Behav. 2023 Jul;7(7):1038-1041. doi: 10.1038/s41562-023-01621-w.

Katherine Christian^{1

2}, Jo-Ann Larkins³, Michael R Doran^{4

5}

¹ Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, Queensland, Australia. kate.christian@qut.edu.au.
² Institute of Innovation, Science and Sustainability, Future Regions Research Centre, Federation University Australia, Churchill, Victoria, Australia. kate.christian@qut.edu.au.
³ Institute of Innovation, Science and Sustainability, Future Regions Research Centre, Federation University Australia, Churchill, Victoria, Australia. jo-ann.larkins@federation.edu.au.
⁴ Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, Queensland, Australia. michael.doran@astrazeneca.com.
⁵ Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA. michael.doran@astrazeneca.com.

No abstract available